There's a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Resmed (RMD – Research Report) and UnitedHealth (UNH – Research Report) with bullish sentiments. Resmed (RMD) RBC Capital analyst Craig Wong-Pan maintained a Buy rating on Resmed on July 18 and set a price target of $246.00. The company's shares closed last Wednesday at $226.90.
https://www.tipranks.com/news/blurbs/wall-street-analysts-are-bullish-on-top-healthcare-picks-180?utm_source=advfn.com&utm_medium=referral
UnitedHealth (NYSE:UNH)
過去 株価チャート
から 9 2022 まで 10 2022 UnitedHealthのチャートをもっと見るにはこちらをクリック
UnitedHealth (NYSE:UNH)
過去 株価チャート
から 10 2021 まで 10 2022 UnitedHealthのチャートをもっと見るにはこちらをクリック